The close association of the degree of systemic inflammation with organ dysfunction and subsequent mortality during bacterial infections in cirrhosis21–23, may explain why an increased prevalence of SBP in patients with the TRAF6 risk haplotype did not translate into increased mortality in our study in presence of adequate treatment. Here, TRAF6 is linked to bacterial infectious disease.